ACAD
Acadia Pharmaceuticals Inc. · Healthcare
EVP, GC, SEC Jennifer J Rhodes sold $162K of Acadia Pharmaceuticals Inc.
Sold$162,491
$23.38Price
6,950Shares
−48%Stake
What ACAD did after the filing
- The stock from Tue, Feb 10 close, $22.70
- −3.0%
- S&P 500, same days
- −5.1%
Measured over 30 trading days, to the Mar 25 close.
Traded Mon, Feb 9. Filed Tue, Feb 10, 1:00 PM ET, during the session. Returns use the Feb 10 close and the Mar 25 close. Not investment advice.